Hematology- Hemostasis Flashcards
1
Q
- Which of the following initiates in vivo
coagulation by activation of factor VII?
A. Protein C
B. Tissue factor
C. Plasmin activator
D. Thrombomodulin
A
B. Tissue factor
2
Q
- Which of the following clotting factors plays a role
in clot formation in vitro, but not in vivo? in vitro
clot formation and not in vivo coagulation?
A. VIIa
B. IIa
C. XIIa
D. Xa
A
C. XIIa
3
Q
- The anticoagulant of choice for most routine
coagulation studies is:
A. Sodium oxalate
B. Sodium citrate
C. Heparin
D. Ethylenediaminetetraacetic acid (EDTA)
A
B. Sodium citrate
4
Q
- Which ratio of anticoagulant-to-blood is correct
for coagulation procedures?
A. 1:4
B. 1:5
C. 1:9
D. 1:10
A
C. 1:9
5
Q
- Which results would be expected for the
prothrombin time (PT) and activated partial
thromboplastin time (APTT) in a patient with
polycythemia?
A. Both prolonged
B. Both shortened
C. Normal PT, prolonged APTT
D. Both normal
A
A. Both prolonged
6
Q
- What reagents are used in the PT test?
A. Thromboplastin and sodium chloride
B. Thromboplastin and potassium chloride
C. Thromboplastin and calcium
D. Actin and calcium chloride
A
C. Thromboplastin and calcium
7
Q
- Which test would be abnormal in a patient with
factor X deficiency?
A. PT only
B. APTT only
C. PT and APTT
D. Thrombin time
A
C. PT and APTT
8
Q
- Which clotting factor is not measured by PT
and APTT tests?
A. Factor VIII
B. Factor IX
C. Factor V
D. Factor XIII
A
D. Factor XIII
9
Q
- A modification of which procedure can be used to
measure fibrinogen?
A. PT
B. APTT
C. Thrombin time
D. Fibrin degradation products
A
C. Thrombin time
10
Q
- Which of the following characterizes vitamin K?
A. It is required for biological activity of fibrinolysis
B. Its activity is enhanced by heparin therapy
C. It is required for carboxylation of glutamate
residues of some coagulation factors
D. It is made by the endothelial cells
A
C. It is required for carboxylation of glutamate
residues of some coagulation factors
11
Q
- Which statement about the fibrinogen/fibrin
degradation product test is correct?
A. It detects early degradation products (X and Y)
B. It is decreased in disseminated intravascular
coagulation (DIC)
C. It evaluates the coagulation system
D. It detects late degradation products (D and E)
A
D. It detects late degradation products (D and E)
12
Q
- Which of the following clotting factors are
measured by the APTT test?
A. II, VII, IX, X
B. VII, X, V, II, I
C. XII, XI, IX, VIII, X, V, II, I
D. XII, VII, X, V, II, I
A
C. XII, XI, IX, VIII, X, V, II, I
13
Q
- Which coagulation test(s) would be abnormal in a
vitamin K–deficient patient?
A. PT only
B. PT and APTT
C. Fibrinogen level
D. Thrombin time
A
B. PT and APTT
14
Q
- Which of the following is correct regarding the
international normalized ratio (INR)?
A. It uses the International Sensitivity Ratio (ISR)
B. It standardizes PT results
C. It standardizes APTT results
D. It is used to monitor heparin therapy
A
B. It standardizes PT results
15
Q
- Which of the following is referred to as an
endogenous activator of plasminogen?
A. Streptokinase
B. Transamidase
C. Tissue plasminogen activator
D. Tissue plasminogen activator inhibitor
A
C. Tissue plasminogen activator